OPRX Marion Odence-Ford sold OptimizeRx Corp shares — SEC Form 4SELLOptimizeRx Corp

Marion Odence-Ford, General Counsel and CCO at OptimizeRx Corp (OPRX), sold 4,000 shares at $15.19 ($61K) on 2024-01-09, disclosed to the SEC on 2024-01-11.

SEC EDGAR Filing

0001628280-24-001190

View on SEC EDGAR

Trade context

Scheduled sale ($61k) by General Counsel and CCO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.

Modest50/100

Nothing distinguishes this filing.

Opportunistic Sell

Trade Context

•Decreased holdings by 26%
•Stock up +113% in previous 3 months
•Part of a 10b5-1 trading plan
•Micro-Cap (Under $300M market cap — highest insider signal alpha)

Filing Info

Filed2024-01-11

Traded2024-01-09

Accession0001628280-24-001190

SourceSEC EDGAR (Historical)

Insider

NameMarion Odence-Ford

TitleGeneral Counsel and CCO

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
OPRX	BUY	2022-08-30	$16K	—	Filing →

Get an email when an insider at OPRX files

Free account. Follow OPRX and up to 10 more companies.

Follow OPRX for free

OPRX Marion Odence-Ford sold OptimizeRx Corp shares — SEC Form 4SELLOptimizeRx Corp

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes